TABLE 2.
Occurrence of acute exacerbation and HBeAg seroreversion after HBeAg seroclearance in different age groups
| Age at HBeAg seroclearance (yr) | No. of patients | No. (%) with:
|
|
|---|---|---|---|
| Acute exacerbation | HBeAg seroreversion | ||
| ≤20 | 12 | 1 (8.3) | 1 (8.3) |
| 20-30 | 60 | 13 (21.7) | 3 (5.0) |
| 30-40 | 71 | 20 (28.2) | 11 (15.5) |
| 40-50 | 45 | 16 (35.6) | 7 (15.6) |
| >50 | 13 | 6 (46.2) | 2 (15.4) |